Data search
Results for MligTC455_48520
| Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
|---|---|---|---|---|---|---|
| MligTC455_48520 | 46 | 0.96 | Mlig455_004433 | Neo: - Age: - |
Mlig455_004433 {REF} {Length: 701} {RNA1310_56623} {RNA815_27009} |
Cumulative graph for MligTC455_48520
Region-enriched expression
| Region | logFC | logCPM | Pvalue | FDR | Specificity |
|---|---|---|---|---|---|
| RegionR1 | 0.544 | 1.473 | 0.99980 | 1.00000 | |
| RegionR2 | 2.264 | 1.473 | 0.31848 | 0.70946 | |
| RegionR3 | 1.176 | 1.473 | 0.38705 | 0.91835 | |
| RegionR4 | 3.391 | 1.473 | 0.09259 | 0.29194 | |
| RegionR5 | 0.193 | 1.473 | 0.65338 | 1.00000 | |
| RegionR6 | -0.431 | 1.473 | 0.82331 | 1.00000 | |
| RegionR7 | -3.558 | 1.473 | 0.99949 | 1.00000 | |
| RegionR8 | -3.58 | 1.473 | 0.99950 | 1.00000 |
Regeneration-enriched expression
| Region | logFC | logCPM | PValue | FDR | Specificity |
|---|---|---|---|---|---|
| RegenerationR1 | -1.385 | 1.473 | 0.99993 | 1.00000 | |
| RegenerationR2 | -1.066 | 1.473 | 0.11721 | 0.53252 | |
| RegenerationR3 | -0.026 | 1.473 | 0.78674 | 0.97761 | |
| RegenerationR4 | -1.557 | 1.473 | 0.28344 | 0.72872 | |
| RegenerationR5 | -1.093 | 1.473 | 0.37336 | 0.78277 | |
| RegenerationR6 | 0.046 | 1.473 | 0.99211 | 1.00000 | |
| RegenerationBL | -0.334 | 1.473 | 0.99977 | 1.00000 | |
| RegenerationTP | -1.243 | 1.473 | 0.99987 | 1.00000 |
Genes with expression patterns similar to MligTC455_48520
| Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | MligTC455_48520 | 46 | 0.96 | Mlig455_004433 | Neo: - Age: - |
6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_004433 {REF} {Length: 701} {RNA1310_56623} {RNA815_27009} | |
| 2. | MligTC455_53413 | 249 | 5.2 | Mlig455_035022 | Neo: - Age: - Region-specific R2: 4.451 Region-enriched R2: 3.023/0.00460 |
RP1 | 4.401 | 0.711 | 0.931 | 0.877 | 0.923 | - | 0.959 | Mlig455_035022 {REF} {Length: 5065} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.8]; Doublecortin [PF03607.19, score=103.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.0]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=473, Expect=5e-146]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=454, Expect=1e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.5, Expect=2e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=698, Expect=0.0]} {RNA1509_57003} {RNA1310_2710} {RNA815_13802.1} |
| 3. | MligTC455_27678 | 355 | 7.4 | Mlig455_070610 | Neo: - Age: - Region-specific R2: 4.724 Region-enriched R2: 3.766/0.00062 |
4.222 | 0.839 | 0.708 | 0.959 | 0.914 | - | 0.802 | Mlig455_070610 {REF} {Length: 725} {RNA1509_17468, RNA1509_34237} {RNA1310_59474, RNA1509_17468, RNA1509_34237} {RNA1509_17468, RNA1509_34237, RNA815_28024} | |
| 4. | MligTC455_53415 | 319 | 6.64 | Mlig455_053444 | Neo: - Age: Up-Down-Down Region-specific R2: 4.862 Region-enriched R2: 4.179/0.00011 |
RP1 | 3.82 | - | 0.910 | 0.981 | 0.957 | - | 0.972 | Mlig455_053444 {REF} {Length: 4944} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.3]; Doublecortin [PF03607.19, score=100.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.5]; Fibroblast growth factor [PF00167.20, score=18.6]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=471, Expect=6e-145]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=453, Expect=3e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.9, Expect=1e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=691, Expect=0.0]} {RNA1509_59703} {RNA1310_2710} {RNA815_17469} |
| 5. | MligTC455_50927 | 254 | 5.29 | Mlig455_070541, Mlig455_070562 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.296 Region-enriched R2: 7.883/0.00008 |
FZD4 | 3.77 | - | 0.916 | 0.938 | 0.951 | - | 0.965 | Mlig455_070541 {REF} {Length: 3522} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=339.1]; Fz domain [PF01392.24, score=88.1]} {Human: ENSG00000174804, FZD4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Mouse: ENSMUSG00000049791, Fzd4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Dmel: FBgn0001085, fz, frizzled, [Score=315, Expect=3e-98]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=284, Expect=5e-87]} {Smed: dd_Smed_v6_7210_0_1, dd_Smed_v6_7210_0_1, [RH, Score=471, Expect=6e-159]} {RNA1509_15834} {RNA1310_3800, RNA1509_15834} {RNA1509_15834, RNA815_19571} Mlig455_070562 {REF} {Length: 3527} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=339.1]; Fz domain [PF01392.24, score=88.1]} {Human: ENSG00000174804, FZD4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Mouse: ENSMUSG00000049791, Fzd4, frizzled class receptor 4, [RH, Score=446, Expect=2e-149]} {Dmel: FBgn0001085, fz, frizzled, [Score=315, Expect=3e-98]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=284, Expect=5e-87]} {Smed: dd_Smed_v6_7210_0_1, dd_Smed_v6_7210_0_1, [RH, Score=470, Expect=8e-159]} {RNA1509_15834} {RNA1310_3800} {RNA815_19571} |
| 6. | MligTC455_38810 | 655 | 13.64 | Mlig455_021157, Mlig455_021360, Mlig455_021587 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.289 Region-enriched R2: 2.927/0.00001 |
NELL2 | 3.752 | 0.983 | 0.913 | 0.922 | - | - | 0.934 | Mlig455_021157 {REF} {Length: 4103} {Smed: dd_Smed_v6_13075_0_2, dd_Smed_v6_13075_0_2, [Score=57.8, Expect=4e-08]} {RNA1509_22586} {RNA1310_1033} {RNA815_17785} Mlig455_021360 {REF} {Length: 7457} {Pfam: Calcium-binding EGF domain [PF07645.17, score=34.6]; EGF domain [PF12947.9, score=33.5]; TNFR/NGFR cysteine-rich region [PF00020.20, score=27.7]; Complement Clr-like EGF-like [PF12662.9, score=20.4]} {Human: ENSG00000184613, NELL2, neural EGFL like 2, [Score=63.5, Expect=4e-09]; ENSG00000168743, NPNT, nephronectin, [Score=62.4, Expect=6e-09]; ENSG00000165973, NELL1, neural EGFL like 1, [Score=60.8, Expect=3e-08]} {Mouse: ENSMUSG00000000402, Egfl6, EGF-like-domain, multiple 6, [Score=63.2, Expect=3e-09]; ENSMUSG00000022454, Nell2, NEL-like 2, [Score=63.2, Expect=3e-09]; ENSMUSG00000002885, Adgre5, adhesion G protein-coupled receptor E5, [Score=62.0, Expect=6e-09]; ENSMUSG00000040998, Npnt, nephronectin, [Score=62.0, Expect=5e-09]} {Dmel: FBgn0035798, frac, faulty attraction, [Score=54.7, Expect=1e-06]} {Celegans: WBGene00022816, fbn-1, FBN-1A.1; FiBrilliN homolog, [Score=68.9, Expect=4e-11]} {Smed: dd_Smed_v6_13075_0_1, dd_Smed_v6_13075_0_1, [RH, Score=146, Expect=9e-35]} {RNA1509_49441} {RNA1310_699, RNA1509_49441} {RNA1509_49441, RNA815_6324} Mlig455_021587 {REF} {Length: 2362} {RNA1509_22586} {RNA1310_1033} {RNA815_22832} |
| 7. | MligTC455_53414 | 331 | 6.9 | Mlig455_053442 | Neo: - Age: - Region-specific R2: 4.308 Region-enriched R2: 3.374/0.00040 |
RP1 | 3.752 | - | 0.910 | 0.914 | 0.955 | - | 0.973 | Mlig455_053442 {REF} {Length: 1156} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.8]; Doublecortin [PF03607.19, score=103.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.0]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=473, Expect=5e-146]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=454, Expect=1e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.5, Expect=2e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=698, Expect=0.0]} {RNA1509_21828} {RNA1310_33070.1} {RNA815_13802.1} |
| 8. | MligTC455_48521 | 56 | 1.17 | Mlig455_004444 | Neo: - Age: - |
3.742 | 0.998 | - | 0.882 | 0.871 | - | 0.991 | Mlig455_004444 {REF} {Length: 3968} {Pfam: GDNF/GAS1 domain [PF02351.18, score=19.4]} {Smed: dd_Smed_v6_19517_0_1, dd_Smed_v6_19517_0_1, [RH, Score=111, Expect=3e-25]} {RNA1509_50708} {RNA1310_13399} {RNA815_27009} | |
| 9. | MligTC455_50171 | 151 | 3.14 | Mlig455_065462 | Neo: - Age: logFC(26M/2M)=0.548 Region-specific R2: 5.212 Region-enriched R2: 5.063/0.00089 Regeneration-downregulated R2: -2.783 Regeneration-depleted R2: -2.783 |
SCNN1A | 3.722 | 0.955 | - | 0.937 | 0.902 | - | 0.928 | Mlig455_065462 {REF} {Length: 3905} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=185.3]} {Human: ENSG00000111319, SCNN1A, sodium channel epithelial 1 alpha subunit, [Score=60.1, Expect=9e-09]} {Mouse: ENSMUSG00000030340, Scnn1a, sodium channel, nonvoltage-gated 1 alpha, [Score=67.0, Expect=5e-11]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=92.8, Expect=1e-19]} {Smed: dd_Smed_v6_16959_0_1, dd_Smed_v6_16959_0_1, [Score=275, Expect=3e-83]} {RNA1509_60030} {RNA1310_56761} {RNA815_31877.1} |
| 10. | MligTC455_21757 | 26 | 0.53 | Mlig455_057867 | Neo: - Age: - |
3.688 | - | 0.885 | 0.959 | 0.922 | - | 0.922 | Mlig455_057867 {REF} {Length: 284} {NoTransDecoderORF} {RNA1310_117997} | |
| 11. | MligTC455_45666 | 652 | 13.58 | Mlig455_013011, Mlig455_013040 | Neo: - Age: Up-Down-Up Region-specific R2: 4.509 Region-enriched R2: 3.140/0.01108 |
3.677 | 0.850 | - | 0.962 | 0.910 | - | 0.955 | Mlig455_013011 {REF} {Length: 1193} {RNA1509_13068} {RNA1310_46610} {RNA815_23273} Mlig455_013040 {REF} {Length: 923} {RNA1509_13068} {RNA1310_46610, RNA1509_13068} {RNA1509_13068, RNA815_23273} |
|
| 12. | MligTC455_50567 | 146 | 3.04 | Mlig455_012858 | Neo: - Age: - Region-specific R2: 6.162 Region-enriched R2: 5.988/0.01054 |
3.629 | 0.900 | 0.867 | 0.954 | 0.908 | - | - | Mlig455_012858 {REF} {Length: 1282} {Pfam: F5/8 type C domain [PF00754.27, score=27.5]} {Smed: dd_Smed_v6_36585_0_1, dd_Smed_v6_36585_0_1, [RH, Score=64.3, Expect=4e-12]} {RNA1310_34633} {RNA815_12537} | |
| 13. | MligTC455_45021 | 381 | 7.95 | Mlig455_046686 | Neo: - Age: Down-Up-Up Region-enriched R2: 3.428/0.03156 |
AVP | 3.597 | 0.973 | - | 0.732 | 0.925 | - | 0.967 | Mlig455_046686 {REF} {Length: 1388} {Pfam: Neurohypophysial hormones, C-terminal Domain [PF00184.19, score=36.2]} {Human: ENSG00000101200, AVP, arginine vasopressin, [Score=54.3, Expect=2e-09]} {Mouse: ENSMUSG00000037727, Avp, arginine vasopressin, [Score=53.1, Expect=3e-09]} {RNA1509_50574} {RNA1310_38922} {RNA815_23813} |
| 14. | MligTC455_53860 | 202 | 4.22 | Mlig455_053523, Mlig455_061000 | Neo: - Age: Up-Down-Down Region-enriched R2: 3.086/0.02665 |
RGS3 | 3.588 | - | 0.819 | 0.938 | 0.880 | - | 0.951 | Mlig455_053523 {REF} {Length: 2125} {Pfam: Regulator of G protein signaling domain [PF00615.21, score=117.0]} {Human: ENSG00000138835, RGS3, regulator of G protein signaling 3, [RH, Score=163, Expect=4e-45]} {Mouse: ENSMUSG00000059810, Rgs3, regulator of G-protein signaling 3, [RH, Score=165, Expect=2e-45]} {Dmel: FBgn0028743, Dhit, Double hit, [Score=109, Expect=2e-27]} {Celegans: WBGene00004350, rgs-7, Regulator of G-protein signaling rgs-7, [RH, Score=130, Expect=1e-34]} {Smed: dd_Smed_v6_8787_0_1, dd_Smed_v6_8787_0_1, [Score=173, Expect=9e-51]} {RNA1310_19330.1} {RNA815_18723} Mlig455_061000 {REF} {Length: 2721} {Pfam: Regulator of G protein signaling domain [PF00615.21, score=117.0]; Dehydrin [PF00257.21, score=20.5]} {Human: ENSG00000138835, RGS3, regulator of G protein signaling 3, [RH, Score=163, Expect=4e-45]} {Mouse: ENSMUSG00000059810, Rgs3, regulator of G-protein signaling 3, [RH, Score=165, Expect=2e-45]} {Dmel: FBgn0028743, Dhit, Double hit, [Score=109, Expect=2e-27]} {Celegans: WBGene00004350, rgs-7, Regulator of G-protein signaling rgs-7, [RH, Score=130, Expect=1e-34]} {Smed: dd_Smed_v6_8787_0_1, dd_Smed_v6_8787_0_1, [Score=173, Expect=8e-51]} {RNA1310_19330.1} {RNA815_18723} |
| 15. | MligTC455_19876 | 135 | 2.82 | Mlig455_024520, Mlig455_024523 | Neo: - Age: - |
3.567 | - | 0.701 | 0.977 | 0.909 | - | 0.980 | Mlig455_024520 {REF} {Length: 2352} {Pfam: CD20-like family [PF04103.17, score=40.9]} {Mouse: ENSMUSG00000048004, Tmem196, transmembrane protein 196, [Score=63.5, Expect=2e-12]} {Smed: dd_Smed_v6_14043_0_1, dd_Smed_v6_14043_0_1, [Score=184, Expect=5e-59]} {RNA1509_25506} {RNA1310_9338} {RNA815_23744} Mlig455_024523 {REF} {Length: 2311} {Smed: dd_Smed_v6_14043_0_1, dd_Smed_v6_14043_0_1, [Score=153, Expect=3e-47]} {RNA1509_25506} {RNA1310_9338} {RNA815_23744} |
|
| 16. | MligTC455_29914 | 44 | 0.91 | Mlig455_027923 | Neo: - Age: Down-Up-Down Region-enriched R2: 8.096/0.00455 |
ANGPTL3 | 3.552 | - | 0.799 | 0.931 | 0.871 | - | 0.951 | Mlig455_027923 {REF} {Length: 1663} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=70.5]} {Human: ENSG00000132855, ANGPTL3, angiopoietin like 3, [Score=60.5, Expect=9e-10]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=59.3, Expect=2e-09]; ENSG00000120332, TNN, tenascin N, [Score=58.9, Expect=3e-09]} {Mouse: ENSMUSG00000015829, Tnr, tenascin R, [Score=62.4, Expect=2e-10]} {Dmel: FBgn0031804, CG9500, [Score=76.3, Expect=6e-16]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=51.2, Expect=3e-07]} {RNA1509_53291} {RNA1310_58974} {RNA815_43288.3} |
| 17. | MligTC455_24108 | 17 | 0.35 | Mlig455_019116 | Neo: - Age: - |
KCNK16 | 3.551 | - | - | 0.970 | 0.779 | 0.880 | 0.922 | Mlig455_019116 {REF} {Length: 1389} {Pfam: Ion channel [PF07885.18, score=118.0]; Ion transport protein [PF00520.33, score=29.1]} {Human: ENSG00000095981, KCNK16, potassium two pore domain channel subfamily K member 16, [Score=155, Expect=5e-44]} {Mouse: ENSMUSG00000023243, Kcnk5, potassium channel, subfamily K, member 5, [RH, Score=141, Expect=3e-37]} {Dmel: FBgn0037690, Task7, TWIK-related acid-sensitive K[+] channel 7, [Score=110, Expect=3e-27]} {Celegans: WBGene00006696, twk-46, TWiK family of potassium channels, [Score=115, Expect=3e-29]} {Smed: dd_Smed_v6_9028_0_1, dd_Smed_v6_9028_0_1, [Score=121, Expect=4e-31]} {RNA1310_125949} |
| 18. | MligTC455_38775 | 266 | 5.54 | Mlig455_066758, Mlig455_069705 | Neo: - Age: - Region-specific R2: 6.147 Region-enriched R2: 5.505/0.02411 |
WNT6 | 3.548 | - | 0.890 | 0.899 | 0.800 | - | 0.959 | Mlig455_066758 {REF} {Length: 2739} {Pfam: wnt family [PF00110.21, score=158.2]} {Human: ENSG00000115596, WNT6, Wnt family member 6, [Score=77.4, Expect=9e-15]; ENSG00000134245, WNT2B, Wnt family member 2B, [Score=74.3, Expect=1e-13]} {Mouse: ENSMUSG00000033227, Wnt6, wingless-type MMTV integration site family, member 6, [Score=74.3, Expect=6e-14]; ENSMUSG00000027840, Wnt2b, wingless-type MMTV integration site family, member 2B, [Score=74.3, Expect=9e-14]} {Dmel: FBgn0031902, Wnt6, Wnt oncogene analog 6, [Score=70.9, Expect=9e-13]} {Celegans: WBGene00000857, cwn-1, [Score=73.9, Expect=4e-14]} {Smed: dd_Smed_v6_13487_0_1, dd_Smed_v6_13487_0_1, [Score=71.2, Expect=3e-13]} {RNA1509_23528} {RNA1310_12823.2} {RNA815_8552} Mlig455_069705 {REF} {Length: 2713} {Pfam: wnt family [PF00110.21, score=158.2]} {Human: ENSG00000115596, WNT6, Wnt family member 6, [Score=77.4, Expect=1e-14]; ENSG00000134245, WNT2B, Wnt family member 2B, [Score=74.3, Expect=1e-13]} {Mouse: ENSMUSG00000033227, Wnt6, wingless-type MMTV integration site family, member 6, [Score=74.3, Expect=7e-14]; ENSMUSG00000027840, Wnt2b, wingless-type MMTV integration site family, member 2B, [Score=73.9, Expect=1e-13]} {Dmel: FBgn0031902, Wnt6, Wnt oncogene analog 6, [Score=70.9, Expect=9e-13]} {Celegans: WBGene00000857, cwn-1, [Score=73.6, Expect=6e-14]} {Smed: dd_Smed_v6_13487_0_1, dd_Smed_v6_13487_0_1, [Score=70.9, Expect=3e-13]} {RNA1509_23528} {RNA1310_12823.1, RNA1509_23528} {RNA1509_23528, RNA815_8552} |
| 19. | MligTC455_16610 | 98 | 2.05 | Mlig455_069894 | Neo: - Age: - Region-enriched R2: 5.254/0.03136 |
WSCD2 | 3.548 | 0.999 | - | 0.748 | 0.868 | - | 0.933 | Mlig455_069894 {REF} {Length: 827} {Pfam: WSC domain [PF01822.21, score=59.2]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=55.1, Expect=4e-09]} {Mouse: ENSMUSG00000020393, Kremen1, kringle containing transmembrane protein 1, [Score=47.8, Expect=9e-07]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=52.4, Expect=2e-08]} {RNA1509_46267} {RNA1310_46146} {RNA815_32275.1} |
| 20. | MligTC455_16781 | 32 | 0.67 | Mlig455_003020, Mlig455_003313 | Neo: - Age: - |
3.541 | - | - | 0.968 | 0.853 | 0.798 | 0.922 | Mlig455_003020 {REF} {Length: 518} {Pfam: Immunoreceptor tyrosine-based activation motif [PF02189.17, score=26.8]} {RNA1310_57787} {RNA815_49158} Mlig455_003313 {REF} {Length: 905} {Pfam: Immunoreceptor tyrosine-based activation motif [PF02189.17, score=74.4]} {RNA1310_57787} {RNA815_49158} |
|
| 21. | MligTC455_54282 | 74 | 1.54 | Mlig455_020191 | Neo: - Age: - |
3.537 | - | 0.752 | 0.915 | 0.916 | - | 0.954 | Mlig455_020191 {REF} {Length: 937} {RNA1509_48973} {RNA1310_40738.2} {RNA815_31898} | |
| 22. | MligTC455_37682 | 225 | 4.68 | Mlig455_022978, Mlig455_023072 | Neo: - Age: Up-Down-Up Region-enriched R7: 2.657/0.03586 |
KCNN2 | 3.512 | 0.994 | 0.772 | - | 0.956 | - | 0.790 | Mlig455_022978 {REF} {Length: 4236} {Pfam: Calcium-activated SK potassium channel [PF03530.16, score=149.3]; Calmodulin binding domain [PF02888.18, score=116.8]; Ion channel [PF07885.18, score=49.6]} {Human: ENSG00000080709, KCNN2, potassium calcium-activated channel subfamily N member 2, [RH, Score=548, Expect=0.0]; ENSG00000143603, KCNN3, potassium calcium-activated channel subfamily N member 3, [RH, Score=539, Expect=1e-180]} {Mouse: ENSMUSG00000054477, Kcnn2, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2, [RH, Score=549, Expect=0.0]; ENSMUSG00000000794, Kcnn3, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3, [RH, Score=541, Expect=0.0]} {Dmel: FBgn0029761, SK, small conductance calcium-activated potassium channel, [RH, Score=637, Expect=0.0]} {Celegans: WBGene00008570, kcnl-2, KCNL-2 variant; KCNN (Potassium K ChaNNel, calcium activated)-Like, [RH, Score=424, Expect=5e-135]} {Smed: dd_Smed_v6_15620_0_1, dd_Smed_v6_15620_0_1, [RH, Score=572, Expect=0.0]} {RNA1509_28013} {RNA1310_5308.1, RNA1509_28013} {RNA1509_28013, RNA815_7768} Mlig455_023072 {REF} {Length: 3426} {Pfam: Calcium-activated SK potassium channel [PF03530.16, score=149.3]; Calmodulin binding domain [PF02888.18, score=116.0]; Ion channel [PF07885.18, score=49.6]} {Human: ENSG00000080709, KCNN2, potassium calcium-activated channel subfamily N member 2, [RH, Score=534, Expect=3e-177]; ENSG00000143603, KCNN3, potassium calcium-activated channel subfamily N member 3, [RH, Score=525, Expect=2e-175]} {Mouse: ENSMUSG00000054477, Kcnn2, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2, [RH, Score=536, Expect=1e-178]; ENSMUSG00000000794, Kcnn3, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3, [RH, Score=528, Expect=1e-176]} {Dmel: FBgn0029761, SK, small conductance calcium-activated potassium channel, [RH, Score=627, Expect=0.0]} {Celegans: WBGene00008570, kcnl-2, KCNL-2 variant; KCNN (Potassium K ChaNNel, calcium activated)-Like, [RH, Score=410, Expect=8e-130]} {Smed: dd_Smed_v6_15620_0_1, dd_Smed_v6_15620_0_1, [RH, Score=559, Expect=0.0]} {RNA1509_28013} {RNA1310_5308.1} {RNA815_7768} |
| 23. | MligTC455_44120 | 125 | 2.61 | Mlig455_041513 | Neo: - Age: Up-Down-Down Region-enriched R2: 7.169/0.00020 |
3.506 | - | 0.760 | 0.965 | 0.833 | - | 0.948 | Mlig455_041513 {REF} {Length: 644} {NoTransDecoderORF} {RNA1310_39164} {RNA815_4344} | |
| 24. | MligTC455_18614 | 342 | 7.13 | Mlig455_021102 | Neo: - Age: logFC(26M/2M)=1.052 Region-specific R2: 6.427 Region-enriched R2: 5.869/0.00003 |
3.501 | 0.955 | - | 0.909 | 0.840 | - | 0.797 | Mlig455_021102 {REF} {Length: 1417} {RNA1509_43477} {RNA1310_26398} {RNA815_11119} | |
| 25. | MligTC455_34655 | 89 | 1.86 | Mlig455_058020, Mlig455_058176 | Neo: - Age: - Region-enriched R2: 5.798/0.00826 |
PPEF1 | 3.5 | - | 0.800 | 0.985 | 0.866 | - | 0.849 | Mlig455_058020 {REF} {Length: 3007} {Pfam: Calcineurin-like phosphoesterase [PF00149.30, score=84.9]; EF-hand domain pair [PF13499.8, score=77.8]; EF hand [PF00036.34, score=66.0]; EF-hand domain pair [PF13833.8, score=52.1]; EF-hand domain [PF13405.8, score=48.4]; EF hand [PF13202.8, score=38.2]; PPP5 TPR repeat region [PF08321.14, score=37.0]; EF-hand domain [PF14658.8, score=23.0]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=20.4]} {Human: ENSG00000086717, PPEF1, protein phosphatase with EF-hand domain 1, [Score=416, Expect=2e-138]} {Mouse: ENSMUSG00000062168, Ppef1, protein phosphatase with EF hand calcium-binding domain 1, [Score=413, Expect=9e-138]} {Dmel: FBgn0265959, rdgC, retinal degeneration C, [Score=404, Expect=3e-134]} {Celegans: WBGene00003969, pef-1, Serine/threonine-protein phosphatase with EF-hands pef-1, [Score=455, Expect=2e-155]} {Smed: dd_Smed_v6_11874_0_2, dd_Smed_v6_11874_0_2, [Score=516, Expect=2e-178]} {RNA1509_3508} {RNA1310_10928.2} {RNA815_11707} Mlig455_058176 {REF} {Length: 3371} {Pfam: Calcineurin-like phosphoesterase [PF00149.30, score=102.6]; EF-hand domain pair [PF13499.8, score=72.6]; EF hand [PF00036.34, score=64.2]; EF-hand domain pair [PF13833.8, score=51.3]; EF-hand domain [PF13405.8, score=46.1]; EF hand [PF13202.8, score=36.7]; PPP5 TPR repeat region [PF08321.14, score=36.6]; EF-hand domain [PF14658.8, score=26.5]; IQ calmodulin-binding motif [PF00612.29, score=21.3]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=19.8]} {Human: ENSG00000086717, PPEF1, protein phosphatase with EF-hand domain 1, [RH, Score=546, Expect=0.0]} {Mouse: ENSMUSG00000062168, Ppef1, protein phosphatase with EF hand calcium-binding domain 1, [Score=520, Expect=3e-177]} {Dmel: FBgn0265959, rdgC, retinal degeneration C, [Score=529, Expect=2e-180]} {Celegans: WBGene00003969, pef-1, Serine/threonine-protein phosphatase with EF-hands pef-1, [Score=598, Expect=0.0]} {Smed: dd_Smed_v6_11874_0_1, dd_Smed_v6_11874_0_1, [Score=671, Expect=0.0]} {RNA1509_3508} {RNA1310_10928.2} {RNA815_11707} |
| 26. | MligTC455_18990 | 13 | 0.28 | Mlig455_069976 | Neo: - Age: - |
SYN1 | 3.499 | - | - | 0.995 | 0.744 | 0.852 | 0.908 | Mlig455_069976 {REF} {Length: 2476} {Pfam: Synapsin, ATP binding domain [PF02750.16, score=235.0]; Synapsin, N-terminal domain [PF02078.18, score=137.7]} {Human: ENSG00000008056, SYN1, synapsin I, [RH, Score=324, Expect=2e-102]; ENSG00000157152, SYN2, synapsin II, [RH, Score=324, Expect=2e-103]; ENSG00000185666, SYN3, synapsin III, [RH, Score=322, Expect=9e-103]} {Mouse: ENSMUSG00000059602, Syn3, synapsin III, [RH, Score=327, Expect=5e-105]; ENSMUSG00000037217, Syn1, synapsin I, [RH, Score=324, Expect=9e-103]; ENSMUSG00000009394, Syn2, synapsin II, [RH, Score=323, Expect=9e-105]} {Dmel: FBgn0004575, Syn, Synapsin, [RH, Score=321, Expect=2e-98]} {Celegans: WBGene00004913, snn-1, SyNapsiN; Synapsin, [Score=163, Expect=6e-45]} {Smed: dd_Smed_v6_3135_0_1, dd_Smed_v6_3135_0_1, [RH, Score=387, Expect=3e-128]} {RNA1509_58931} {RNA1310_22468.1} {RNA815_2386} |
| 27. | MligTC455_51780 | 138 | 2.88 | Mlig455_046894 | Neo: - Age: Down-Up-Down Region-enriched R2: 6.174/0.00338 |
PNPO | 3.482 | 0.975 | 0.815 | 0.856 | 0.836 | - | - | Mlig455_046894 {REF} {Length: 2339} {Pfam: Pyridoxamine 5'-phosphate oxidase [PF01243.22, score=78.4]; Pyridoxine 5'-phosphate oxidase C-terminal dimerisation region [PF10590.11, score=69.2]; Pyridoxamine 5'-phosphate oxidase [PF12766.9, score=22.3]} {Human: ENSG00000108439, PNPO, pyridoxamine 5'-phosphate oxidase, [Score=182, Expect=7e-57]} {Mouse: ENSMUSG00000018659, Pnpo, pyridoxine 5'-phosphate oxidase, [RH, Score=184, Expect=1e-57]} {Dmel: FBgn0051472, sgll, sugarlethal, [Score=168, Expect=6e-52]} {Celegans: WBGene00018996, F57B9.1, Putative pyridoxamine 5'-phosphate oxidase, [RH, Score=200, Expect=1e-64]} {Smed: dd_Smed_v6_5086_0_1, dd_Smed_v6_5086_0_1, [RH, Score=177, Expect=2e-55]} {RNA1509_54079} {RNA1310_31564.1, RNA1509_54079} {RNA1509_54079, RNA815_34098} |
| 28. | MligTC455_29915 | 50 | 1.04 | Mlig455_027934 | Neo: - Age: Down-Up-Up Region-enriched R2: 6.881/0.04464 |
ANGPTL1 | 3.474 | - | 0.871 | 0.939 | 0.710 | - | 0.954 | Mlig455_027934 {REF} {Length: 2265} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=43.0]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=48.9, Expect=9e-06]} {Dmel: FBgn0031804, CG9500, [Score=53.1, Expect=9e-08]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=49.7, Expect=1e-06]} {RNA1509_53291} {RNA1310_38229.1} {RNA815_10579.1} |
| 29. | MligTC455_45027 | 719 | 14.97 | Mlig455_023328 | Neo: - Age: logFC(26M/2M)=-0.432 |
CFAP161 | 3.455 | 0.957 | 0.834 | - | 0.901 | - | 0.763 | Mlig455_023328 {REF} {Length: 1614} {Human: ENSG00000156206, CFAP161, cilia and flagella associated protein 161, [RH, Score=165, Expect=1e-48]} {Mouse: ENSMUSG00000011154, Cfap161, cilia and flagella associated protein 161, [RH, Score=177, Expect=2e-53]} {Dmel: FBgn0085486, CG34457, [RH, Score=110, Expect=5e-28]} {Smed: dd_Smed_v6_8229_0_1, dd_Smed_v6_8229_0_1, [RH, Score=226, Expect=7e-73]} {RNA1509_34203, RNA1509_55466} {RNA1310_22539.1, RNA1509_34203} {RNA1509_34203, RNA815_9025} |
| 30. | MligTC455_46452 | 134 | 2.79 | Mlig455_048151 | Neo: - Age: - Region-specific R2: 6.389 Region-enriched R2: 7.075/0.00014 Regeneration-downregulated R2: -3.162 Regeneration-depleted R2: -3.162 |
3.455 | 0.794 | - | 0.964 | 0.828 | - | 0.869 | Mlig455_048151 {REF} {Length: 618} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=25.7]} {RNA1310_62963} {RNA815_31352} | |
| 31. | MligTC455_46117 | 384 | 7.99 | Mlig455_030128, Mlig455_030194, Mlig455_067972 | Neo: - Age: - |
3.454 | 0.916 | - | 0.717 | 0.951 | - | 0.870 | Mlig455_030128 {REF} {Length: 3020} {Smed: dd_Smed_v6_9728_0_1, dd_Smed_v6_9728_0_1, [Score=70.9, Expect=2e-12]} {RNA1509_52528} {RNA1310_8681} {RNA815_38958} Mlig455_030194 {REF} {Length: 3159} {Smed: dd_Smed_v6_9728_0_2, dd_Smed_v6_9728_0_2, [Score=82.0, Expect=6e-16]} {RNA1509_52528} {RNA1310_8681} {RNA815_30875} Mlig455_067972 {REF} {Length: 3149} {Smed: dd_Smed_v6_9728_0_2, dd_Smed_v6_9728_0_2, [Score=80.9, Expect=1e-15]} {RNA1509_52528} {RNA1310_8681} {RNA815_30875} |
|
| 32. | MligTC455_19279 | 4576 | 95.33 | Mlig455_057411 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=-0.654 Region-specific R2: 5.173 Region-enriched R2: 4.585/0.00000 |
CHRNA10 | 3.441 | - | 0.771 | 0.853 | 0.840 | - | 0.977 | Mlig455_057411 {REF} {Length: 1075} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=85.3]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=91.3, Expect=1e-20]} {Mouse: ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=92.0, Expect=7e-21]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=88.2, Expect=1e-19]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=110, Expect=2e-27]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=120, Expect=4e-31]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=96.3, Expect=8e-23]} {RNA1509_1306} {RNA1310_34970} {RNA815_15305.1} |
| 33. | MligTC455_15898 | 111 | 2.32 | Mlig455_034780 | Neo: - Age: - Region-enriched R2: 4.729/0.00758 |
STOM | 3.429 | 0.797 | 0.719 | 0.993 | 0.920 | - | - | Mlig455_034780 {REF} {Length: 2617} {Pfam: SPFH domain / Band 7 family [PF01145.27, score=108.6]} {Human: ENSG00000148175, STOM, stomatin, [Score=298, Expect=5e-99]; ENSG00000133115, STOML3, stomatin like 3, [Score=293, Expect=3e-97]} {Mouse: ENSMUSG00000026880, Stom, stomatin, [Score=294, Expect=6e-98]; ENSMUSG00000027744, Stoml3, stomatin (Epb7.2)-like 3, [Score=285, Expect=3e-94]} {Dmel: FBgn0260657, CG42540, [Score=308, Expect=1e-100]} {Celegans: WBGene00006064, sto-2, Stomatin-2, [Score=309, Expect=5e-103]} {Smed: dd_Smed_v6_6562_0_1, dd_Smed_v6_6562_0_1, [RH, Score=389, Expect=5e-134]} {RNA1509_39119} {RNA1310_7313, RNA1509_39119} {RNA1509_39119, RNA815_17831} |
| 34. | MligTC455_16439 | 147 | 3.07 | Mlig455_026017, Mlig455_070446 | Neo: - Age: - Region-enriched R2: 5.463/0.01159 |
SYN3 | 3.423 | 0.968 | 0.721 | 0.868 | 0.866 | - | - | Mlig455_026017 {REF} {Length: 1744} {Pfam: Synapsin, ATP binding domain [PF02750.16, score=157.5]} {Human: ENSG00000185666, SYN3, synapsin III, [Score=169, Expect=2e-47]; ENSG00000008056, SYN1, synapsin I, [Score=167, Expect=2e-46]; ENSG00000157152, SYN2, synapsin II, [Score=165, Expect=2e-49]} {Mouse: ENSMUSG00000037217, Syn1, synapsin I, [Score=169, Expect=2e-47]; ENSMUSG00000009394, Syn2, synapsin II, [Score=168, Expect=5e-48]; ENSMUSG00000059602, Syn3, synapsin III, [Score=168, Expect=1e-47]} {Dmel: FBgn0004575, Syn, Synapsin, [Score=169, Expect=3e-48]} {Celegans: WBGene00004913, snn-1, SyNapsiN; Synapsin, [Score=112, Expect=3e-28]} {Smed: dd_Smed_v6_3135_0_2, dd_Smed_v6_3135_0_2, [Score=167, Expect=3e-49]} {RNA1310_44259} {RNA815_33612} Mlig455_070446 {REF} {Length: 1739} {Pfam: Synapsin, ATP binding domain [PF02750.16, score=159.2]} {Human: ENSG00000185666, SYN3, synapsin III, [Score=169, Expect=2e-47]; ENSG00000008056, SYN1, synapsin I, [Score=168, Expect=1e-46]; ENSG00000157152, SYN2, synapsin II, [Score=164, Expect=4e-49]} {Mouse: ENSMUSG00000037217, Syn1, synapsin I, [Score=170, Expect=1e-47]; ENSMUSG00000059602, Syn3, synapsin III, [Score=168, Expect=2e-47]; ENSMUSG00000009394, Syn2, synapsin II, [Score=166, Expect=2e-47]} {Dmel: FBgn0004575, Syn, Synapsin, [Score=175, Expect=2e-50]} {Celegans: WBGene00004913, snn-1, SyNapsiN; Synapsin, [Score=107, Expect=2e-26]} {Smed: dd_Smed_v6_3135_0_2, dd_Smed_v6_3135_0_2, [Score=173, Expect=3e-51]} {RNA1310_44259} {RNA815_33612} |
| 35. | MligTC455_14856 | 14 | 0.29 | Mlig455_023184 | Neo: - Age: - |
ANGPTL7 | 3.42 | - | - | 0.989 | 0.722 | 0.748 | 0.961 | Mlig455_023184 {REF} {Length: 1290} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=129.4]; PAN domain [PF00024.28, score=23.8]} {Human: ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=105, Expect=1e-25]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=103, Expect=3e-24]} {Mouse: ENSMUSG00000028989, Angptl7, angiopoietin-like 7, [Score=104, Expect=1e-25]; ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=102, Expect=4e-24]} {Dmel: FBgn0033312, CG8642, [Score=96.7, Expect=2e-22]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=98.6, Expect=5e-23]} {RNA1509_58115} {RNA1310_36699.1} {RNA815_17918.1} |
| 36. | MligTC455_40989 | 801 | 16.68 | Mlig455_016294 | Neo: - Age: logFC(26M/2M)=0.270 |
PKD2 | 3.415 | 0.967 | 0.751 | 0.745 | - | - | 0.952 | Mlig455_016294 {REF} {Length: 3179} {Pfam: Polycystin cation channel [PF08016.14, score=486.5]; Ion transport protein [PF00520.33, score=90.3]; EF hand [PF00036.34, score=23.7]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=718, Expect=0.0]; ENSG00000107593, PKD2L1, polycystin 2 like 1, transient receptor potential cation channel, [RH, Score=712, Expect=0.0]} {Mouse: ENSMUSG00000037578, Pkd2l1, polycystic kidney disease 2-like 1, [RH, Score=704, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [RH, Score=310, Expect=2e-91]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [RH, Score=370, Expect=7e-116]} {Smed: dd_Smed_v6_13327_0_1, dd_Smed_v6_13327_0_1, [RH, Score=743, Expect=0.0]} {RNA1509_14023, RNA1509_24240} {RNA1310_4836.1, RNA1509_14023, RNA1509_24240} {RNA1509_14023, RNA1509_24240, RNA815_4677} |
| 37. | MligTC455_48848 | 282 | 5.87 | Mlig455_005151, Mlig455_021613 | Neo: - Age: - Region-specific R2: 4.764 Region-enriched R2: 5.813/0.00000 |
SYT3 | 3.398 | - | 0.707 | 0.768 | 0.947 | - | 0.976 | Mlig455_005151 {REF} {Length: 1574} {Pfam: C2 domain [PF00168.32, score=55.1]} {Human: ENSG00000213023, SYT3, synaptotagmin 3, [Score=68.6, Expect=5e-12]; ENSG00000011347, SYT7, synaptotagmin 7, [Score=67.0, Expect=1e-11]} {Mouse: ENSMUSG00000030731, Syt3, synaptotagmin III, [Score=69.3, Expect=2e-12]} {Dmel: FBgn0261089, Sytalpha, Synaptotagmin alpha, [Score=63.2, Expect=1e-10]} {Celegans: WBGene00004921, snt-1, Synaptotagmin-1, [Score=66.6, Expect=5e-12]} {Smed: dd_Smed_v6_25279_0_1, dd_Smed_v6_25279_0_1, [Score=85.1, Expect=2e-18]} {RNA1310_20857} {RNA815_8396} Mlig455_021613 {REF} {Length: 1574} {Pfam: C2 domain [PF00168.32, score=55.1]} {Human: ENSG00000213023, SYT3, synaptotagmin 3, [Score=68.6, Expect=5e-12]; ENSG00000011347, SYT7, synaptotagmin 7, [Score=67.0, Expect=1e-11]} {Mouse: ENSMUSG00000030731, Syt3, synaptotagmin III, [Score=69.3, Expect=2e-12]} {Dmel: FBgn0261089, Sytalpha, Synaptotagmin alpha, [Score=63.2, Expect=1e-10]} {Celegans: WBGene00004921, snt-1, Synaptotagmin-1, [Score=66.6, Expect=5e-12]} {Smed: dd_Smed_v6_25279_0_1, dd_Smed_v6_25279_0_1, [Score=85.1, Expect=2e-18]} {RNA1310_20857} {RNA815_8396} |
| 38. | MligTC455_51536 | 78 | 1.62 | Mlig455_040699 | Neo: - Age: - |
3.396 | 0.988 | 0.786 | 0.843 | - | - | 0.779 | Mlig455_040699 {REF} {Length: 2015} {RNA1310_34295.1} {RNA815_22630} | |
| 39. | MligTC455_23567 | 109 | 2.27 | Mlig455_013185 | Neo: - Age: Down-Up-Down |
BCHE | 3.393 | 0.984 | 0.776 | 0.775 | 0.858 | - | - | Mlig455_013185 {REF} {Length: 4455} {Pfam: Carboxylesterase family [PF00135.30, score=432.1]; alpha/beta hydrolase fold [PF07859.15, score=35.5]} {Human: ENSG00000114200, BCHE, butyrylcholinesterase, [Score=317, Expect=9e-99]; ENSG00000087085, ACHE, acetylcholinesterase (Cartwright blood group), [Score=312, Expect=2e-96]} {Mouse: ENSMUSG00000027792, Bche, butyrylcholinesterase, [Score=324, Expect=3e-101]} {Dmel: FBgn0000024, Ace, Acetylcholine esterase, [Score=249, Expect=8e-73]} {Celegans: WBGene00000035, ace-1, Acetylcholinesterase 1, [Score=327, Expect=2e-102]} {Smed: dd_Smed_v6_15930_0_1, dd_Smed_v6_15930_0_1, [RH, Score=412, Expect=4e-134]} {RNA1509_26775} {RNA1310_8383.1} {RNA815_10983} |
| 40. | MligTC455_36372 | 925 | 19.28 | Mlig455_005680 | Neo: - Age: logFC(26M/2M)=2.101 Region-enriched R2: 7.233/0.00006 |
3.388 | - | 0.717 | 0.917 | 0.965 | 0.789 | - | Mlig455_005680 {REF} {Length: 1993} {RNA1509_18409, RNA1509_31432} {RNA1310_82233, RNA1509_18409, RNA1509_31432} {RNA1509_18409, RNA1509_31432, RNA815_42934} | |
| 41. | MligTC455_21182 | 238 | 4.96 | Mlig455_000068, Mlig455_063733 | Neo: - Age: Down-Up-Up Region-enriched R4: 5.301/0.04587 |
3.383 | - | 0.768 | 0.955 | 0.825 | - | 0.835 | Mlig455_000068 {REF} {Length: 468} {Pfam: Pancreatic hormone peptide [PF00159.20, score=23.7]} {RNA1310_81800.1} {RNA815_55075} Mlig455_063733 {REF} {Length: 531} {Pfam: Pancreatic hormone peptide [PF00159.20, score=20.7]} {RNA1310_81800.1} {RNA815_55075} |
|
| 42. | MligTC455_26004 | 161 | 3.34 | Mlig455_005523, Mlig455_036228 | Neo: - Age: logFC(26M/2M)=0.483 Region-enriched R2: 3.880/0.02863 |
3.36 | - | 0.957 | 0.925 | 0.774 | - | 0.704 | Mlig455_005523 {REF} {Length: 3106} {RNA1509_54312} {RNA1310_125315} {RNA815_31978} Mlig455_036228 {REF} {Length: 3817} {RNA1509_54312} {RNA1310_75243} {RNA815_31978} |
|
| 43. | MligTC455_19278 | 4335 | 90.31 | Mlig455_057304, Mlig455_070944 | Neo: - Age: logFC(26M/2M)=0.686 Region-specific R2: 5.590 Region-enriched R2: 5.465/0.00000 |
CHRNA10 | 3.355 | - | 0.732 | 0.860 | 0.802 | - | 0.961 | Mlig455_057304 {REF} {Length: 1001} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=71.6]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=77.0, Expect=2e-16]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=75.9, Expect=4e-16]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=75.5, Expect=6e-16]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=73.9, Expect=2e-15]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=93.6, Expect=2e-22]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=100, Expect=5e-25]} {Smed: dd_Smed_v6_11955_0_1, dd_Smed_v6_11955_0_1, [Score=82.8, Expect=8e-19]} {RNA1509_23115} {RNA1310_34970} {RNA815_15305.1} Mlig455_070944 {REF} {Length: 1060} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=88.2]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=95.9, Expect=6e-22]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=96.3, Expect=3e-22]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=94.7, Expect=1e-21]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=112, Expect=7e-28]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=118, Expect=4e-30]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=98.6, Expect=2e-23]} {RNA1509_23115, RNA1509_43907, RNA1509_9432} {RNA1310_34970, RNA1509_23115, RNA1509_43907, RNA1509_9432} {RNA1509_23115, RNA1509_43907, RNA1509_9432, RNA815_15305.1} |
| 44. | MligTC455_47172 | 76 | 1.59 | Mlig455_027719 | Neo: - Age: - |
3.338 | - | 0.734 | 0.788 | 0.862 | - | 0.954 | Mlig455_027719 {REF} {Length: 647} {NoTransDecoderORF} {RNA1509_59103} {RNA1310_42906} {RNA815_5816} | |
| 45. | MligTC455_19276 | 1694 | 35.28 | Mlig455_057303 | Neo: - Age: Down-Down-Up Region-specific R2: 5.711 Region-enriched R2: 6.117/0.00000 |
3.332 | - | 0.703 | 0.898 | 0.769 | - | 0.962 | Mlig455_057303 {REF} {Length: 1196} {Pfam: TATA-binding related factor (TRF) of subunit 20 of Mediator complex [PF08612.13, score=80.6]} {Smed: dd_Smed_v6_9879_0_1, dd_Smed_v6_9879_0_1, [RH, Score=73.9, Expect=1e-15]} {RNA1509_58478} {RNA1310_35292} {RNA815_20171} | |
| 46. | MligTC455_19277 | 1013 | 21.11 | Mlig455_059600 | Neo: - Age: - Region-specific R2: 4.883 Region-enriched R2: 5.766/0.00000 |
3.316 | - | 0.720 | 0.908 | 0.713 | - | 0.975 | Mlig455_059600 {REF} {Length: 827} {NoTransDecoderORF} {RNA1509_43907} {RNA1310_81348} | |
| 47. | MligTC455_16166 | 638 | 13.28 | Mlig455_045546, Mlig455_052637 | Neo: - Age: - |
B3GALT5 | 3.293 | 0.821 | 0.820 | 0.701 | 0.951 | - | - | Mlig455_045546 {REF} {Length: 2520} {Pfam: Galactosyltransferase [PF01762.23, score=159.0]} {Human: ENSG00000183778, B3GALT5, beta-1,3-galactosyltransferase 5, [RH, Score=129, Expect=2e-32]} {Mouse: ENSMUSG00000034780, B3galt1, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1, [Score=113, Expect=5e-27]; ENSMUSG00000074892, B3galt5, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5, [Score=111, Expect=2e-26]; ENSMUSG00000074004, B3gnt6, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase), [Score=110, Expect=1e-25]} {Dmel: FBgn0035558, CG11357, [RH, Score=147, Expect=3e-38]} {Celegans: WBGene00000270, bre-5, Beta-1,3-galactosyltransferase bre-5, [Score=72.8, Expect=3e-14]} {Smed: dd_Smed_v6_12783_0_1, dd_Smed_v6_12783_0_1, [Score=149, Expect=5e-40]} {RNA1509_45540} {RNA1310_2435} {RNA815_25407} Mlig455_052637 {REF} {Length: 2225} {Pfam: Galactosyltransferase [PF01762.23, score=159.1]} {Human: ENSG00000183778, B3GALT5, beta-1,3-galactosyltransferase 5, [RH, Score=125, Expect=3e-31]} {Mouse: ENSMUSG00000034780, B3galt1, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1, [Score=114, Expect=1e-27]; ENSMUSG00000074004, B3gnt6, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase), [Score=109, Expect=3e-25]} {Dmel: FBgn0035558, CG11357, [Score=143, Expect=1e-36]} {Celegans: WBGene00000270, bre-5, Beta-1,3-galactosyltransferase bre-5, [Score=71.2, Expect=3e-13]} {Smed: dd_Smed_v6_12783_0_1, dd_Smed_v6_12783_0_1, [Score=152, Expect=3e-41]} {RNA1509_45540} {RNA1310_2435} {RNA815_25407} |
| 48. | MligTC455_43524 | 172 | 3.58 | Mlig455_031179 | Neo: - Age: - Region-enriched R2: 3.416/0.00534 |
SLC30A2 | 3.274 | 0.956 | - | 0.764 | 0.820 | - | 0.734 | Mlig455_031179 {REF} {Length: 2311} {Pfam: Cation efflux family [PF01545.23, score=155.3]; Dimerisation domain of Zinc Transporter [PF16916.7, score=21.1]} {Human: ENSG00000158014, SLC30A2, solute carrier family 30 member 2, [Score=350, Expect=3e-117]} {Mouse: ENSMUSG00000028836, Slc30a2, solute carrier family 30 (zinc transporter), member 2, [Score=362, Expect=3e-122]} {Dmel: FBgn0028516, ZnT35C, Zinc transporter 35C, [RH, Score=324, Expect=1e-106]} {Celegans: WBGene00011821, cdf-2, Cation Diffusion Facilitator family, [RH, Score=324, Expect=7e-108]} {Smed: dd_Smed_v6_5529_0_1, dd_Smed_v6_5529_0_1, [Score=432, Expect=4e-150]} {RNA1509_37229} {RNA1310_13324.1} {RNA815_5520} |
| 49. | MligTC455_31696 | 99 | 2.06 | Mlig455_054925 | Neo: - Age: Down-Down-Up |
3.236 | - | - | 0.767 | 0.802 | 0.713 | 0.954 | Mlig455_054925 {REF} {Length: 1987} {RNA1310_24838} {RNA815_18727} | |
| 50. | MligTC455_44810 | 226 | 4.72 | Mlig455_013293, Mlig455_035940, Mlig455_058406, Mlig455_058409 | Neo: - Age: - Region-specific R2: 6.204 Region-enriched R2: 5.509/0.00501 |
3.123 | 0.706 | - | 0.702 | 0.765 | - | 0.950 | Mlig455_013293 {REF} {Length: 1362} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=56.6, Expect=2e-09]} {RNA1310_28961.1} {RNA815_27532} Mlig455_035940 {REF} {Length: 1652} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=55.8, Expect=3e-09]} {RNA1310_28961.1} {RNA815_27532} Mlig455_058406 {REF} {Length: 991} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=55.8, Expect=4e-09]} {RNA1310_28961.1} {RNA815_27532} Mlig455_058409 {REF} {Length: 1311} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=55.8, Expect=3e-09]} {RNA1310_28961.1} {RNA815_27532} |
|
| 51. | MligTC455_33832 | 112 | 2.34 | Mlig455_029411 | Neo: - Age: Up-Down-Down Region-enriched R2: 5.300/0.00016 |
GLRA3 | 2.889 | - | - | 0.978 | 0.936 | - | 0.975 | Mlig455_029411 {REF} {Length: 3686} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=149.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=84.5]} {Human: ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=257, Expect=5e-80]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=253, Expect=3e-78]; ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=250, Expect=4e-77]} {Mouse: ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=251, Expect=2e-77]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=249, Expect=5e-77]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=248, Expect=2e-76]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=243, Expect=1e-74]} {Dmel: FBgn0024963, GluClalpha, [Score=253, Expect=2e-78]} {Celegans: WBGene00000233, avr-15, GluClalpha2B protein, [Score=259, Expect=7e-81]} {Smed: dd_Smed_v6_11342_0_1, dd_Smed_v6_11342_0_1, [RH, Score=480, Expect=1e-167]} {RNA1509_35986} {RNA1310_35528} {RNA815_35433} |
| 52. | MligTC455_19875 | 82 | 1.71 | Mlig455_024408 | Neo: - Age: Down-Up-Down |
2.875 | - | - | 0.985 | 0.923 | - | 0.967 | Mlig455_024408 {REF} {Length: 2479} {Pfam: CD20-like family [PF04103.17, score=40.9]} {Mouse: ENSMUSG00000048004, Tmem196, transmembrane protein 196, [Score=63.5, Expect=2e-12]} {Smed: dd_Smed_v6_14043_0_1, dd_Smed_v6_14043_0_1, [Score=184, Expect=5e-59]} {RNA1509_25506} {RNA1310_4968.1} {RNA815_23744} | |
| 53. | MligTC455_50172 | 243 | 5.05 | Mlig455_067182 | Neo: - Age: Down-Up-Up Region-specific R2: 6.036 Region-enriched R2: 6.524/0.00000 |
2.844 | - | - | 0.975 | 0.912 | - | 0.957 | Mlig455_067182 {REF} {Length: 638} {Pfam: Pancreatic hormone peptide [PF00159.20, score=47.5]} {RNA1509_60030} {RNA1310_56761, RNA1509_60030} {RNA1509_60030, RNA815_31877.1} | |
| 54. | MligTC455_14898 | 41 | 0.86 | Mlig455_011988 | Neo: - Age: - |
2.826 | - | 0.909 | 0.995 | - | - | 0.922 | Mlig455_011988 {REF} {Length: 858} {Pfam: Lectin C-type domain [PF00059.23, score=28.2]} {RNA1509_20946} {RNA1310_48952} {RNA815_4785.1} | |
| 55. | MligTC455_50660 | 81 | 1.7 | Mlig455_019591 | Neo: - Age: - |
SLC9B2 | 2.81 | - | 0.906 | - | 0.968 | - | 0.936 | Mlig455_019591 {REF} {Length: 2686} {Pfam: Sodium/hydrogen exchanger family [PF00999.23, score=30.0]} {Human: ENSG00000164038, SLC9B2, solute carrier family 9 member B2, [Score=124, Expect=1e-31]} {Mouse: ENSMUSG00000037994, Slc9b2, solute carrier family 9, subfamily B (NHA2, cation proton antiporter 2), member 2, [Score=116, Expect=1e-28]; ENSMUSG00000050150, Slc9b1, solute carrier family 9, subfamily B (NHA1, cation proton antiporter 1), member 1, [Score=112, Expect=2e-27]} {Dmel: FBgn0263390, Nha2, Na[+]/H[+] hydrogen antiporter 2, [Score=113, Expect=1e-27]} {Celegans: WBGene00009618, F41E7.2, [Score=70.9, Expect=2e-13]} {Smed: dd_Smed_v6_7736_0_1, dd_Smed_v6_7736_0_1, [Score=148, Expect=1e-43]} {RNA1509_34461} {RNA1310_39553.1} {RNA815_32589} |
| 56. | MligTC455_50601 | 21 | 0.44 | Mlig455_018462 | Neo: - Age: - |
2.807 | - | 0.917 | 0.993 | 0.897 | - | - | Mlig455_018462 {REF} {Length: 2878} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=164.0]} {Smed: dd_Smed_v6_37545_0_1, dd_Smed_v6_37545_0_1, [Score=117, Expect=1e-27]} {RNA1310_8235} {RNA815_10456.1} | |
| 57. | MligTC455_19249 | 90 | 1.86 | Mlig455_054092 | Neo: - Age: Down-Up-Up Region-enriched R2: 7.298/0.00139 |
2.802 | - | - | 0.997 | 0.836 | - | 0.969 | Mlig455_054092 {REF} {Length: 667} {TRANSSPLICED} {RNA1509_57448} {RNA1310_51394, RNA1509_57448} {RNA1509_57448, RNA815_26076} | |
| 58. | MligTC455_23957 | 33 | 0.68 | Mlig455_015196, Mlig455_068736 | Neo: - Age: - Region-enriched R2: 7.683/0.01527 |
2.802 | - | - | 0.962 | 0.918 | - | 0.922 | Mlig455_015196 {REF} {Length: 1138} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=63.8]} {RNA1509_30941} {RNA1310_34740} {RNA815_15663} Mlig455_068736 {REF} {Length: 1580} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=64.0]} {RNA1310_32395.1} {RNA815_15663} |
|
| 59. | MligTC455_38355 | 110 | 2.29 | Mlig455_039715, Mlig455_039769 | Neo: - Age: - |
KCNB2 | 2.797 | - | 0.917 | - | 0.956 | - | 0.924 | Mlig455_039715 {REF} {Length: 3883} {Pfam: Ion transport protein [PF00520.33, score=114.4]; BTB/POZ domain [PF02214.24, score=75.0]; Ion channel [PF07885.18, score=43.6]} {Human: ENSG00000182674, KCNB2, potassium voltage-gated channel subfamily B member 2, [Score=218, Expect=3e-60]; ENSG00000129159, KCNC1, potassium voltage-gated channel subfamily C member 1, [Score=213, Expect=2e-60]; ENSG00000158445, KCNB1, potassium voltage-gated channel subfamily B member 1, [Score=213, Expect=7e-59]; ENSG00000166006, KCNC2, potassium voltage-gated channel subfamily C member 2, [Score=210, Expect=2e-59]; ENSG00000116396, KCNC4, potassium voltage-gated channel subfamily C member 4, [Score=209, Expect=7e-59]} {Mouse: ENSMUSG00000092083, Kcnb2, potassium voltage gated channel, Shab-related subfamily, member 2, [Score=219, Expect=5e-61]; ENSMUSG00000050556, Kcnb1, potassium voltage gated channel, Shab-related subfamily, member 1, [Score=218, Expect=1e-60]; ENSMUSG00000058975, Kcnc1, potassium voltage gated channel, Shaw-related subfamily, member 1, [Score=214, Expect=8e-61]; ENSMUSG00000035681, Kcnc2, potassium voltage gated channel, Shaw-related subfamily, member 2, [Score=213, Expect=6e-60]} {Dmel: FBgn0003386, Shaw, Shaker cognate w, [Score=230, Expect=8e-67]} {Celegans: WBGene00008819, shw-1, SHaW family of potassium channels, [Score=236, Expect=3e-69]} {Smed: dd_Smed_v6_11886_0_1, dd_Smed_v6_11886_0_1, [RH, Score=592, Expect=0.0]} {RNA1509_22940} {RNA1310_17926} {RNA815_8687.1} Mlig455_039769 {REF} {Length: 4176} {Pfam: Ion transport protein [PF00520.33, score=116.7]; BTB/POZ domain [PF02214.24, score=75.0]; Ion channel [PF07885.18, score=43.6]; Polycystin cation channel [PF08016.14, score=20.7]} {Human: ENSG00000182674, KCNB2, potassium voltage-gated channel subfamily B member 2, [Score=219, Expect=8e-61]; ENSG00000129159, KCNC1, potassium voltage-gated channel subfamily C member 1, [Score=216, Expect=2e-61]; ENSG00000158445, KCNB1, potassium voltage-gated channel subfamily B member 1, [Score=215, Expect=2e-59]; ENSG00000166006, KCNC2, potassium voltage-gated channel subfamily C member 2, [Score=213, Expect=2e-60]; ENSG00000116396, KCNC4, potassium voltage-gated channel subfamily C member 4, [Score=213, Expect=4e-60]; ENSG00000131398, KCNC3, potassium voltage-gated channel subfamily C member 3, [Score=210, Expect=4e-58]} {Mouse: ENSMUSG00000092083, Kcnb2, potassium voltage gated channel, Shab-related subfamily, member 2, [Score=221, Expect=2e-61]; ENSMUSG00000050556, Kcnb1, potassium voltage gated channel, Shab-related subfamily, member 1, [Score=219, Expect=4e-61]; ENSMUSG00000058975, Kcnc1, potassium voltage gated channel, Shaw-related subfamily, member 1, [Score=216, Expect=6e-62]; ENSMUSG00000035681, Kcnc2, potassium voltage gated channel, Shaw-related subfamily, member 2, [Score=215, Expect=6e-61]; ENSMUSG00000062785, Kcnc3, potassium voltage gated channel, Shaw-related subfamily, member 3, [Score=211, Expect=1e-58]} {Dmel: FBgn0003386, Shaw, Shaker cognate w, [Score=231, Expect=2e-67]} {Celegans: WBGene00008819, shw-1, SHaW family of potassium channels, [Score=239, Expect=2e-70]} {Smed: dd_Smed_v6_11886_0_1, dd_Smed_v6_11886_0_1, [RH, Score=595, Expect=0.0]} {RNA1509_22940} {RNA1310_17926} {RNA815_8687.1} |
| 60. | MligTC455_53546 | 130 | 2.72 | Mlig455_013326, Mlig455_013334 | Neo: - Age: - Region-enriched R2: 6.753/0.01892 |
MMP9 | 2.79 | - | - | 0.918 | 0.899 | - | 0.973 | Mlig455_013326 {REF} {Length: 1449} {Pfam: Fibronectin type II domain [PF00040.21, score=92.5]} {Human: ENSG00000100985, MMP9, matrix metallopeptidase 9, [RH, Score=87.8, Expect=3e-18]} {Mouse: ENSMUSG00000017737, Mmp9, matrix metallopeptidase 9, [RH, Score=82.4, Expect=1e-16]; ENSMUSG00000031740, Mmp2, matrix metallopeptidase 2, [RH, Score=78.6, Expect=2e-15]} {Smed: dd_Smed_v6_14558_0_1, dd_Smed_v6_14558_0_1, [RH, Score=138, Expect=3e-38]} {RNA1310_38631} {RNA815_51136} Mlig455_013334 {REF} {Length: 1398} {Pfam: Fibronectin type II domain [PF00040.21, score=92.1]} {Human: ENSG00000100985, MMP9, matrix metallopeptidase 9, [RH, Score=89.4, Expect=1e-18]} {Mouse: ENSMUSG00000017737, Mmp9, matrix metallopeptidase 9, [RH, Score=84.0, Expect=4e-17]} {Smed: dd_Smed_v6_12601_0_1, dd_Smed_v6_12601_0_1, [RH, Score=140, Expect=2e-38]} {RNA1310_38631} {RNA815_51136} |
| 61. | MligTC455_52281 | 122 | 2.54 | Mlig455_054688 | Neo: - Age: - Region-enriched R2: 3.102/0.03108 |
2.785 | 0.997 | - | 0.925 | - | - | 0.863 | Mlig455_054688 {REF} {Length: 852} {RNA1509_17653} {RNA1310_86153} {RNA815_32362} | |
| 62. | MligTC455_19040 | 49 | 1.03 | Mlig455_003437 | Neo: - Age: - Region-enriched R2: 6.133/0.00615 |
CAV1 | 2.784 | 0.963 | - | 0.905 | 0.916 | - | - | Mlig455_003437 {REF} {Length: 808} {Pfam: Caveolin [PF01146.19, score=118.3]} {Human: ENSG00000105974, CAV1, caveolin 1, [Score=101, Expect=7e-28]} {Mouse: ENSMUSG00000007655, Cav1, caveolin 1, caveolae protein, [Score=102, Expect=2e-28]} {Celegans: WBGene00000301, cav-1, Caveolin-1, [Score=73.6, Expect=9e-17]} {Smed: dd_Smed_v6_13481_0_1, dd_Smed_v6_13481_0_1, [RH, Score=142, Expect=8e-45]} {RNA1509_53381} {RNA1310_97043} {RNA815_32565} |
| 63. | MligTC455_44328 | 858 | 17.88 | Mlig455_026172 | Neo: - Age: Down-Up-Up Region-specific R2: 4.714 Region-enriched R2: 4.385/0.00000 |
2.784 | - | - | 0.961 | 0.875 | - | 0.948 | Mlig455_026172 {REF} {Length: 661} {RNA1509_32102, RNA1509_34635} {RNA1310_60068, RNA1509_32102, RNA1509_34635} {RNA1509_32102, RNA1509_34635, RNA815_37486} | |
| 64. | MligTC455_43095 | 294 | 6.13 | Mlig455_028880 | Neo: - Age: - Region-enriched R2: 5.606/0.00021 |
2.783 | - | - | 0.877 | 0.930 | - | 0.976 | Mlig455_028880 {REF} {Length: 822} {RNA1509_32622} {RNA1310_67920, RNA1509_32622} {RNA1509_32622, RNA815_31932.2} | |
| 65. | MligTC455_17850 | 65 | 1.35 | Mlig455_002427 | Neo: - Age: - |
2.778 | 0.986 | - | - | 0.900 | 0.892 | - | Mlig455_002427 {REF} {Length: 474} {NoTransDecoderORF} {RNA1310_58520.2} {RNA815_36774} | |
| 66. | MligTC455_41036 | 281 | 5.86 | Mlig455_057198 | Neo: - Age: - Region-specific R2: 5.284 Region-enriched R2: 4.243/0.00075 |
2.775 | - | - | 0.955 | 0.885 | - | 0.935 | Mlig455_057198 {REF} {Length: 538} {Pfam: Pancreatic hormone peptide [PF00159.20, score=41.9]} {RNA1509_42071} {RNA1310_74103, RNA1509_42071} {RNA1509_42071, RNA815_38377} | |
| 67. | MligTC455_50778 | 36 | 0.76 | Mlig455_042296 | Neo: - Age: - |
GPR50 | 2.766 | - | - | 0.980 | 0.864 | - | 0.922 | Mlig455_042296 {REF} {Length: 1415} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=116.3]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=40.0]; Olfactory receptor [PF13853.8, score=34.3]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=33.9]} {Human: ENSG00000102195, GPR50, G protein-coupled receptor 50, [Score=124, Expect=4e-31]; ENSG00000134640, MTNR1B, melatonin receptor 1B, [Score=119, Expect=2e-30]} {Mouse: ENSMUSG00000054764, Mtnr1a, melatonin receptor 1A, [Score=120, Expect=4e-31]; ENSMUSG00000056380, Gpr50, G-protein-coupled receptor 50, [Score=119, Expect=2e-29]; ENSMUSG00000050901, Mtnr1b, melatonin receptor 1B, [Score=118, Expect=5e-30]} {Dmel: FBgn0038980, Octbeta1R, Octopamine beta1 receptor, [Score=92.0, Expect=1e-20]} {Celegans: WBGene00006428, tkr-3, TachyKinin Receptor family, [Score=69.7, Expect=4e-13]} {Smed: dd_Smed_v6_65999_0_1, dd_Smed_v6_65999_0_1, [Score=84.7, Expect=1e-18]} {RNA1310_66047} {RNA815_34066} |
| 68. | MligTC455_50777 | 40 | 0.83 | Mlig455_042072 | Neo: - Age: - |
MTNR1B | 2.757 | - | - | 0.989 | 0.853 | - | 0.915 | Mlig455_042072 {REF} {Length: 2881} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=78.0]; Olfactory receptor [PF13853.8, score=24.3]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=22.0]} {Human: ENSG00000134640, MTNR1B, melatonin receptor 1B, [Score=94.4, Expect=2e-21]; ENSG00000168412, MTNR1A, melatonin receptor 1A, [Score=90.1, Expect=5e-20]} {Mouse: ENSMUSG00000050901, Mtnr1b, melatonin receptor 1B, [Score=94.0, Expect=2e-21]; ENSMUSG00000054764, Mtnr1a, melatonin receptor 1A, [Score=89.4, Expect=6e-20]} {Dmel: FBgn0004514, Oct-TyrR, Octopamine-Tyramine receptor, [Score=57.0, Expect=7e-09]} {Celegans: WBGene00006428, tkr-3, TachyKinin Receptor family, [Score=52.0, Expect=2e-07]} {Smed: dd_Smed_v6_19535_0_1, dd_Smed_v6_19535_0_1, [Score=95.5, Expect=2e-22]} {RNA1310_66047} {RNA815_34066} |
| 69. | MligTC455_26091 | 161 | 3.36 | Mlig455_047190 | Neo: - Age: - Region-enriched R2: 4.521/0.00020 |
2.753 | - | 0.876 | 0.958 | - | - | 0.919 | Mlig455_047190 {REF} {Length: 2450} {Pfam: Lectin C-type domain [PF00059.23, score=23.6]} {RNA1509_2912} {RNA1310_27113} {RNA815_24719} | |
| 70. | MligTC455_15184 | 33 | 0.69 | Mlig455_065087 | Neo: - Age: - |
2.743 | - | - | 0.973 | 0.846 | - | 0.924 | Mlig455_065087 {REF} {Length: 2555} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=183.3]} {Mouse: ENSMUSG00000030340, Scnn1a, sodium channel, nonvoltage-gated 1 alpha, [Score=48.5, Expect=1e-05]} {Celegans: WBGene00009073, delm-1, DEgenerin Linked to Mechanosensation, [Score=68.2, Expect=1e-11]} {Smed: dd_Smed_v6_37545_0_1, dd_Smed_v6_37545_0_1, [RH, Score=125, Expect=3e-30]} {RNA1310_11413} {RNA815_11497} | |
| 71. | MligTC455_19410 | 194 | 4.04 | Mlig455_047838 | Neo: - Age: Down-Up-Up Region-specific R2: 5.170 Region-enriched R2: 5.689/0.00000 |
2.743 | - | - | 0.972 | 0.885 | - | 0.886 | Mlig455_047838 {REF} {Length: 724} {TRANSSPLICED} {RNA1509_54915} {RNA1310_53549} {RNA815_27051} | |
| 72. | MligTC455_36194 | 30 | 0.61 | Mlig455_064360, Mlig455_064382 | Neo: - Age: - |
B3GNT4 | 2.742 | - | 0.774 | 0.994 | - | - | 0.974 | Mlig455_064360 {REF} {Length: 3119} {Pfam: Galactosyltransferase [PF01762.23, score=116.7]} {Human: ENSG00000176383, B3GNT4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=101, Expect=5e-23]} {Mouse: ENSMUSG00000031803, B3gnt3, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, [Score=94.7, Expect=9e-21]; ENSMUSG00000051650, B3gnt2, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2, [Score=94.0, Expect=2e-20]; ENSMUSG00000067370, B3galt4, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4, [Score=93.6, Expect=3e-20]; ENSMUSG00000029431, B3gnt4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=93.2, Expect=2e-20]; ENSMUSG00000022686, B3gnt5, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5, [Score=91.7, Expect=1e-19]} {Dmel: FBgn0031988, CG8668, [Score=90.1, Expect=8e-19]} {Celegans: WBGene00007104, B0024.15, Hexosyltransferase, [RH, Score=90.9, Expect=8e-20]} {Smed: dd_Smed_v6_9789_0_1, dd_Smed_v6_9789_0_1, [Score=165, Expect=5e-47]} {RNA1310_43172} {RNA815_26726} Mlig455_064382 {REF} {Length: 3084} {Pfam: Galactosyltransferase [PF01762.23, score=116.7]} {Human: ENSG00000176383, B3GNT4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=101, Expect=5e-23]} {Mouse: ENSMUSG00000031803, B3gnt3, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, [Score=94.7, Expect=9e-21]; ENSMUSG00000051650, B3gnt2, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2, [Score=94.4, Expect=2e-20]; ENSMUSG00000029431, B3gnt4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=93.6, Expect=2e-20]; ENSMUSG00000067370, B3galt4, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4, [Score=93.6, Expect=2e-20]; ENSMUSG00000022686, B3gnt5, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5, [Score=92.0, Expect=9e-20]} {Dmel: FBgn0031988, CG8668, [Score=90.1, Expect=8e-19]} {Celegans: WBGene00007104, B0024.15, Hexosyltransferase, [RH, Score=90.9, Expect=8e-20]} {Smed: dd_Smed_v6_9789_0_1, dd_Smed_v6_9789_0_1, [Score=165, Expect=5e-47]} {RNA1310_43172} {RNA815_26726} |
| 73. | MligTC455_38699 | 267 | 5.56 | Mlig455_054929 | Neo: - Age: Up-Down-Down Region-enriched R2: 2.183/0.01222 |
COLEC10 | 2.741 | - | 0.866 | 0.962 | 0.913 | - | - | Mlig455_054929 {REF} {Length: 1403} {Pfam: Lectin C-type domain [PF00059.23, score=45.4]} {Human: ENSG00000184374, COLEC10, collectin subfamily member 10, [Score=50.4, Expect=2e-07]} {Mouse: ENSMUSG00000038591, Colec10, collectin sub-family member 10, [Score=47.8, Expect=1e-06]} {RNA1509_22697} {RNA1310_23822} {RNA815_11460} |
| 74. | MligTC455_13866 | 60 | 1.26 | Mlig455_059198 | Neo: - Age: - |
2.739 | - | - | 0.955 | 0.856 | - | 0.928 | Mlig455_059198 {REF} {Length: 561} {NoTransDecoderORF} {RNA1310_89423} {RNA815_50610} | |
| 75. | MligTC455_15112 | 80 | 1.67 | Mlig455_038148 | Neo: - Age: - Region-enriched R2: 4.134/0.00646 |
2.739 | 0.973 | - | - | 0.906 | - | 0.860 | Mlig455_038148 {REF} {Length: 836} | |
| 76. | MligTC455_36371 | 1892 | 39.41 | Mlig455_005636 | Neo: - Age: Down-Down-Up Region-enriched R2: 7.119/0.00007 |
C6orf120 | 2.738 | - | - | 0.911 | 0.963 | 0.864 | - | Mlig455_005636 {REF} {Length: 4589} {TRANSSPLICED} {Pfam: Putative cytokine, C6ORF120 [PF17065.7, score=46.3]} {Human: ENSG00000185127, C6orf120, chromosome 6 open reading frame 120, [Score=52.8, Expect=5e-08]} {Mouse: ENSMUSG00000050088, 1600012H06Rik, RIKEN cDNA 1600012H06 gene, [Score=52.4, Expect=5e-08]} {RNA1509_33302, RNA1509_46654} {RNA1310_15958, RNA1509_46654} {RNA1509_46654, RNA815_10779} |
| 77. | MligTC455_38227 | 131 | 2.73 | Mlig455_049364 | Neo: - Age: Down-Up-Up Region-enriched R2: 5.468/0.02435 |
2.737 | 0.991 | - | 0.889 | 0.857 | - | - | Mlig455_049364 {REF} {Length: 726} {RNA1509_22173} {RNA1310_65747} {RNA815_15489} | |
| 78. | MligTC455_19524 | 100 | 2.09 | Mlig455_010263 | Neo: - Age: Down-Up-Down Region-enriched R2: 4.437/0.01311 |
2.736 | - | - | 0.984 | 0.831 | - | 0.921 | Mlig455_010263 {REF} {Length: 2969} {RNA1310_11925.1} {RNA815_27110} | |
| 79. | MligTC455_43072 | 81 | 1.68 | Mlig455_042521 | Neo: - Age: Down-Up-Down Region-enriched R2: 5.590/0.02161 |
2.735 | 0.984 | - | - | 0.849 | - | 0.902 | Mlig455_042521 {REF} {Length: 1049} {RNA1509_46101} {RNA1310_32444} {RNA815_30668} | |
| 80. | MligTC455_45769 | 79 | 1.65 | Mlig455_018116 | Neo: - Age: - |
2.735 | - | - | 0.919 | 0.849 | - | 0.967 | Mlig455_018116 {REF} {Length: 3312} {Pfam: NACHT domain [PF05729.14, score=33.6]; AAA ATPase domain [PF13191.8, score=25.1]; AAA domain [PF13401.8, score=19.4]} {Smed: dd_Smed_v6_9074_0_1, dd_Smed_v6_9074_0_1, [Score=138, Expect=2e-33]} {RNA1509_44893} {RNA1310_38241} {RNA815_33748} | |
| 81. | MligTC455_53240 | 1601 | 33.35 | Mlig455_025555 | Neo: - Age: - Region-specific R2: 4.178 Region-enriched R2: 2.883/0.00000 |
2.733 | - | - | 0.885 | 0.950 | - | 0.898 | Mlig455_025555 {REF} {Length: 2163} {Pfam: Low-density lipoprotein receptor domain class A [PF00057.20, score=28.0]} {Dmel: FBgn0051221, CG31221, [RH, Score=69.7, Expect=2e-14]} {Celegans: WBGene00010290, F58H1.7, [Score=64.7, Expect=4e-13]} {Smed: dd_Smed_v6_2598_0_1, dd_Smed_v6_2598_0_1, [RH, Score=168, Expect=3e-53]} {RNA1509_58542} {RNA1310_40950, RNA1509_58542} {RNA1509_58542, RNA815_19778.1} | |
| 82. | MligTC455_47712 | 80 | 1.66 | Mlig455_044833 | Neo: - Age: - |
2.723 | 0.918 | - | - | 0.853 | - | 0.952 | Mlig455_044833 {REF} {Length: 564} {RNA1509_55855} {RNA1310_87612} {RNA815_50831} | |
| 83. | MligTC455_41823 | 300 | 6.25 | Mlig455_022277 | Neo: - Age: - Region-enriched R2: 3.150/0.00185 |
2.72 | 0.899 | - | 0.956 | 0.865 | - | - | Mlig455_022277 {REF} {Length: 753} {RNA1509_49797} {RNA1310_60350} {RNA815_30999} | |
| 84. | MligTC455_31799 | 74 | 1.54 | Mlig455_026276, Mlig455_026280 | Neo: - Age: Down-Up-Down |
TRIM2, TRIM3 | 2.711 | 0.992 | - | - | 0.766 | - | 0.953 | Mlig455_026276 {REF} {Length: 2251} {TRANSSPLICED} {Pfam: NHL repeat [PF01436.23, score=30.9]} {Human: ENSG00000110171, TRIM3, tripartite motif containing 3, [Score=66.6, Expect=9e-11]; ENSG00000109654, TRIM2, tripartite motif containing 2, [Score=64.3, Expect=4e-10]} {Mouse: ENSMUSG00000036989, Trim3, tripartite motif-containing 3, [Score=66.2, Expect=7e-11]; ENSMUSG00000027993, Trim2, tripartite motif-containing 2, [Score=64.3, Expect=3e-10]} {RNA1509_15622} {RNA1310_14145.1} {RNA815_3900.1} Mlig455_026280 {REF} {Length: 2260} {Pfam: NHL repeat [PF01436.23, score=30.6]} {Human: ENSG00000109654, TRIM2, tripartite motif containing 2, [Score=61.2, Expect=3e-09]} {Mouse: ENSMUSG00000027993, Trim2, tripartite motif-containing 2, [Score=61.2, Expect=2e-09]} {Celegans: WBGene00003597, nhl-1, RING finger protein nhl-1, [Score=50.8, Expect=2e-06]} {RNA1509_23300} {RNA1310_14145.1} {RNA815_3900.1} |
| 85. | MligTC455_46886 | 51 | 1.05 | Mlig455_015258 | Neo: - Age: - Region-enriched R2: 4.468/0.04690 |
PRKG2 | 2.711 | - | - | 0.987 | 0.906 | - | 0.818 | Mlig455_015258 {REF} {Length: 3110} {Pfam: Protein kinase domain [PF00069.27, score=225.4]; Cyclic nucleotide-binding domain [PF00027.31, score=118.6]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=117.9]; Kinase-like [PF14531.8, score=25.3]} {Human: ENSG00000138669, PRKG2, protein kinase cGMP-dependent 2, [RH, Score=668, Expect=0.0]} {Mouse: ENSMUSG00000029334, Prkg2, protein kinase, cGMP-dependent, type II, [RH, Score=669, Expect=0.0]} {Dmel: FBgn0000442, Pkg21D, Protein kinase, cGMP-dependent at 21D, [RH, Score=683, Expect=0.0]} {Celegans: WBGene00001173, egl-4, cGMP-dependent protein kinase egl-4, [Score=667, Expect=0.0]} {Smed: dd_Smed_v6_6967_0_1, dd_Smed_v6_6967_0_1, [RH, Score=672, Expect=0.0]} {RNA1509_26653} {RNA1310_15330.1} {RNA815_26005} |
| 86. | MligTC455_38875 | 37 | 0.78 | Mlig455_029375, Mlig455_029415 | Neo: - Age: logFC(26M/2M)=-0.939 |
GRIK2 | 2.709 | 0.994 | - | - | 0.801 | - | 0.914 | Mlig455_029375 {REF} {Length: 3713} {Pfam: Ligand-gated ion channel [PF00060.28, score=88.9]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=58.3]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=34.5]; Receptor family ligand binding region [PF01094.30, score=20.4]} {Human: ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=136, Expect=2e-32]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=137, Expect=9e-33]} {Dmel: FBgn0038837, CG3822, [Score=150, Expect=4e-37]} {Celegans: WBGene00001613, glr-2, Glutamate receptor 2, [Score=126, Expect=1e-29]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=242, Expect=3e-72]} {RNA1310_67049} {RNA815_49856} Mlig455_029415 {REF} {Length: 2520} {Pfam: Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=25.5]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [Score=73.9, Expect=5e-14]} {RNA1310_74947} {RNA815_49856} |
| 87. | MligTC455_17363 | 62 | 1.28 | Mlig455_003936 | Neo: - Age: - |
2.707 | - | - | 0.954 | 0.831 | - | 0.922 | Mlig455_003936 {REF} {Length: 1252} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=45.9]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=26.4]} {RNA1310_47889} {RNA815_24646} | |
| 88. | MligTC455_53333 | 44 | 0.91 | Mlig455_019019, Mlig455_055684 | Neo: - Age: Up-Down-Up Region-enriched R4: 4.725/0.03950 |
CHRNA7 | 2.707 | - | - | 0.864 | 0.862 | - | 0.981 | Mlig455_019019 {REF} {Length: 2615} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=154.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=93.9]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=210, Expect=2e-59]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=208, Expect=5e-59]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=207, Expect=8e-59]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=206, Expect=3e-58]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=209, Expect=1e-59]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=205, Expect=3e-58]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=221, Expect=3e-63]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=190, Expect=7e-53]} {Smed: dd_Smed_v6_9503_0_1, dd_Smed_v6_9503_0_1, [Score=426, Expect=5e-142]} {RNA1509_56207} {RNA1310_26355} {RNA815_26644} Mlig455_055684 {REF} {Length: 2604} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=154.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=94.7]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=211, Expect=9e-60]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=209, Expect=3e-59]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=208, Expect=5e-59]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=207, Expect=7e-59]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=209, Expect=9e-60]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=204, Expect=1e-57]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=222, Expect=1e-63]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=190, Expect=6e-53]} {Smed: dd_Smed_v6_9503_0_1, dd_Smed_v6_9503_0_1, [Score=427, Expect=3e-142]} {RNA1509_56207} {RNA1310_26355} {RNA815_26644} |
| 89. | MligTC455_43602 | 1418 | 29.54 | Mlig455_053986 | Neo: - Age: - Region-specific R2: 4.626 Region-enriched R2: 3.844/0.00000 Regeneration-downregulated R2: -2.432 Regeneration-depleted R2: -2.432 |
2.703 | - | - | 0.970 | 0.822 | - | 0.911 | Mlig455_053986 {REF} {Length: 2161} {RNA1509_15576} {RNA1310_12096.1} {RNA815_32931} | |
| 90. | MligTC455_19819 | 67 | 1.39 | Mlig455_042327, Mlig455_047107 | Neo: - Age: - |
2.699 | - | 0.892 | - | 0.846 | - | 0.961 | Mlig455_042327 {REF} {Length: 1414} {RNA1310_83687} Mlig455_047107 {REF} {Length: 1283} {RNA1310_83687} |
|
| 91. | MligTC455_46543 | 178 | 3.7 | Mlig455_000344, Mlig455_067946 | Neo: - Age: - Region-specific R2: 6.098 Region-enriched R2: 6.851/0.00000 |
2.695 | - | 0.815 | 0.962 | 0.918 | - | - | Mlig455_000344 {REF} {Length: 1920} {RNA1310_82457} {RNA815_33120} Mlig455_067946 {REF} {Length: 1217} {RNA1310_99435} |
|
| 92. | MligTC455_45032 | 56 | 1.16 | Mlig455_034186 | Neo: - Age: - |
KREMEN1 | 2.693 | 0.978 | - | 0.793 | - | - | 0.922 | Mlig455_034186 {REF} {Length: 1010} {Pfam: WSC domain [PF01822.21, score=53.3]} {Human: ENSG00000183762, KREMEN1, kringle containing transmembrane protein 1, [Score=51.2, Expect=3e-07]} {Mouse: ENSMUSG00000020393, Kremen1, kringle containing transmembrane protein 1, [Score=53.9, Expect=3e-08]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=47.8, Expect=3e-06]} {RNA1310_39474.1} {RNA815_33128} |
| 93. | MligTC455_19079 | 218 | 4.54 | Mlig455_008746, Mlig455_008760 | Neo: - Age: Down-Up-Up Region-specific R2: 6.705 Region-enriched R2: 6.864/0.00152 |
2.692 | - | - | 0.832 | 0.892 | - | 0.968 | Mlig455_008746 {REF} {Length: 652} {RNA1310_75395.1} {RNA815_42524} Mlig455_008760 {REF} {Length: 1051} {RNA1310_75395.1} {RNA815_42524} |
|
| 94. | MligTC455_11558 | 137 | 2.85 | Mlig455_058259 | Neo: - Age: logFC(26M/2M)=-0.792 |
2.691 | - | - | 0.976 | 0.813 | - | 0.902 | Mlig455_058259 {REF} {Length: 896} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=19.9]} {RNA1509_58923} {RNA1310_41706, RNA1509_58923} {RNA1509_58923, RNA815_20876} | |
| 95. | MligTC455_47420 | 218 | 4.54 | Mlig455_017159, Mlig455_048110 | Neo: - Age: - Region-specific R2: 6.469 Region-enriched R2: 5.851/0.00135 |
2.689 | - | - | 0.848 | 0.867 | - | 0.974 | Mlig455_017159 {REF} {Length: 1062} {RNA1509_35349} {RNA1310_81586} Mlig455_048110 {REF} {Length: 527} {RNA1310_81586} |
|
| 96. | MligTC455_06407 | 25 | 0.52 | Mlig455_055014 | Neo: - Age: - |
2.684 | - | - | 0.985 | - | 0.797 | 0.902 | Mlig455_055014 {REF} {Length: 492} {NoTransDecoderORF} | |
| 97. | MligTC455_40687 | 28 | 0.58 | Mlig455_040563, Mlig455_062078 | Neo: - Age: - |
PDE1C | 2.684 | - | - | 0.958 | 0.802 | - | 0.924 | Mlig455_040563 {REF} {Length: 1798} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=268.1]; 3'5'-cyclic nucleotide phosphodiesterase N-terminal [PF08499.14, score=29.0]} {Human: ENSG00000154678, PDE1C, phosphodiesterase 1C, [Score=362, Expect=2e-117]; ENSG00000115252, PDE1A, phosphodiesterase 1A, [Score=358, Expect=2e-117]} {Mouse: ENSMUSG00000004347, Pde1c, phosphodiesterase 1C, [Score=362, Expect=5e-118]; ENSMUSG00000059173, Pde1a, phosphodiesterase 1A, calmodulin-dependent, [Score=362, Expect=7e-120]} {Dmel: FBgn0264815, Pde1c, Phosphodiesterase 1c, [Score=346, Expect=4e-108]} {Celegans: WBGene00011433, pde-1, Probable 3',5'-cyclic phosphodiesterase pde-1, [Score=347, Expect=3e-113]} {Smed: dd_Smed_v6_21546_0_1, dd_Smed_v6_21546_0_1, [Score=396, Expect=7e-133]} {RNA1310_80402} Mlig455_062078 {REF} {Length: 1807} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=268.6]; 3'5'-cyclic nucleotide phosphodiesterase N-terminal [PF08499.14, score=29.1]} {Human: ENSG00000154678, PDE1C, phosphodiesterase 1C, [Score=356, Expect=3e-115]; ENSG00000115252, PDE1A, phosphodiesterase 1A, [Score=355, Expect=5e-116]} {Mouse: ENSMUSG00000059173, Pde1a, phosphodiesterase 1A, calmodulin-dependent, [Score=359, Expect=1e-118]; ENSMUSG00000004347, Pde1c, phosphodiesterase 1C, [Score=356, Expect=8e-116]} {Dmel: FBgn0264815, Pde1c, Phosphodiesterase 1c, [Score=347, Expect=2e-108]} {Celegans: WBGene00011433, pde-1, Probable 3',5'-cyclic phosphodiesterase pde-1, [Score=347, Expect=3e-113]} {Smed: dd_Smed_v6_26758_0_1, dd_Smed_v6_26758_0_1, [Score=394, Expect=3e-132]} {RNA1509_46211} {RNA1310_80402} {RNA815_55704} |
| 98. | MligTC455_50389 | 19 | 0.39 | Mlig455_059799 | Neo: - Age: - |
2.683 | - | - | - | 0.772 | 0.971 | 0.940 | Mlig455_059799 {REF} {Length: 1159} {Pfam: LIM domain [PF00412.24, score=54.9]} {Dmel: FBgn0085354, CG34325, [Score=55.1, Expect=6e-09]} {RNA1310_54844} {RNA815_43129} | |
| 99. | MligTC455_29797 | 2469 | 51.44 | Mlig455_011428 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=-0.328 Region-enriched R2: 5.791/0.00000 |
2.679 | - | - | 0.920 | 0.971 | - | 0.788 | Mlig455_011428 {REF} {Length: 902} {RNA1509_21417, RNA1509_23190, RNA1509_31800, RNA1509_3881, RNA1509_41776, RNA1509_43586} {RNA1310_44752, RNA1509_21417, RNA1509_23190, RNA1509_31800, RNA1509_3881, RNA1509_41776, RNA1509_43586} {RNA1509_21417, RNA1509_23190, RNA1509_31800, RNA1509_3881, RNA1509_41776, RNA1509_43586, RNA815_21540} | |
| 100. | MligTC455_45731 | 76 | 1.59 | Mlig455_003947, Mlig455_003964, Mlig455_005981 | Neo: - Age: Up-Down-Down |
TTLL7 | 2.675 | - | - | 0.847 | 0.971 | - | 0.857 | Mlig455_003947 {REF} {Length: 4060} {Pfam: Tubulin-tyrosine ligase family [PF03133.17, score=212.9]; Sugar-transfer associated ATP-grasp [PF14397.8, score=23.9]; YheC/D like ATP-grasp [PF14398.8, score=21.3]} {Human: ENSG00000137941, TTLL7, tubulin tyrosine ligase like 7, [Score=351, Expect=4e-107]} {Mouse: ENSMUSG00000036745, Ttll7, tubulin tyrosine ligase-like family, member 7, [Score=347, Expect=1e-103]} {Dmel: FBgn0039501, CG5987, [Score=235, Expect=3e-65]} {Celegans: WBGene00019230, ttll-11, Tubulin Tyrosine Ligase Like, [Score=158, Expect=4e-40]} {Smed: dd_Smed_v6_13600_0_1, dd_Smed_v6_13600_0_1, [Score=313, Expect=3e-91]} {RNA1310_17573} {RNA815_57268} Mlig455_003964 {REF} {Length: 3783} {Pfam: Tubulin-tyrosine ligase family [PF03133.17, score=213.2]; Sugar-transfer associated ATP-grasp [PF14397.8, score=23.9]; YheC/D like ATP-grasp [PF14398.8, score=21.3]} {Human: ENSG00000137941, TTLL7, tubulin tyrosine ligase like 7, [Score=353, Expect=2e-109]} {Mouse: ENSMUSG00000036745, Ttll7, tubulin tyrosine ligase-like family, member 7, [Score=349, Expect=2e-104]} {Dmel: FBgn0039501, CG5987, [Score=234, Expect=4e-65]} {Celegans: WBGene00019230, ttll-11, Tubulin Tyrosine Ligase Like, [Score=157, Expect=7e-40]} {Smed: dd_Smed_v6_13600_0_1, dd_Smed_v6_13600_0_1, [Score=312, Expect=4e-91]} {RNA1310_17573} {RNA815_57268} Mlig455_005981 {REF} {Length: 4222} {Pfam: Tubulin-tyrosine ligase family [PF03133.17, score=213.3]; Sugar-transfer associated ATP-grasp [PF14397.8, score=23.7]; YheC/D like ATP-grasp [PF14398.8, score=21.1]} {Human: ENSG00000137941, TTLL7, tubulin tyrosine ligase like 7, [Score=353, Expect=2e-107]} {Mouse: ENSMUSG00000036745, Ttll7, tubulin tyrosine ligase-like family, member 7, [Score=349, Expect=9e-104]} {Dmel: FBgn0039501, CG5987, [Score=235, Expect=5e-65]} {Celegans: WBGene00019230, ttll-11, Tubulin Tyrosine Ligase Like, [Score=157, Expect=9e-40]} {Smed: dd_Smed_v6_13600_0_1, dd_Smed_v6_13600_0_1, [Score=314, Expect=3e-91]} {RNA1310_17573} {RNA815_57268} |
There are 816 more genes with r >= 0.95